PharmaPatch

PharmaPatch is an Israeli biotechnology and medical technology company focused on the development of advanced transdermal drug delivery systems. The company's core innovation is a "smart patch" designed to deliver large molecules and peptides, such as parathyroid hormone (PTH) and insulin, which traditionally require frequent injections. By utilizing a proprietary active delivery mechanism, PharmaPatch aims to provide a non-invasive, controlled-release alternative that improves patient compliance and therapeutic outcomes for chronic conditions. The company operates within the Trendlines Group incubator and leverages expertise in micro-electronics and drug formulation to address the limitations of passive transdermal patches.